Prevalence of the metabolic syndrome in patients with borderline personality disorder: results from a cross-sectional study
| Autor: | Kai G. Kahl, Joachim Cordes, Christian Lösch, Helge Frieling, Ulrich Schweiger, Susanne Moebus, Christoph U. Correll, Wiebke Greggersen, Chakrapani Balijepalli |
|---|---|
| Rok vydání: | 2011 |
| Předmět: |
Olanzapine
Adult Male medicine.medical_specialty Medizin Binge-eating disorder Borderline Personality Disorder Risk Factors Internal medicine Germany mental disorders medicine Prevalence Humans Pharmacology (medical) Risk factor Borderline personality disorder Biological Psychiatry Abdominal obesity Metabolic Syndrome Psychological Tests Anthropometry Panic disorder General Medicine Middle Aged medicine.disease Diagnostic and Statistical Manual of Mental Disorders Psychiatry and Mental health Endocrinology Cross-Sectional Studies Quetiapine Female Metabolic syndrome medicine.symptom Psychology medicine.drug |
| Zdroj: | European archives of psychiatry and clinical neuroscience. 263(3) |
| ISSN: | 1433-8491 |
| Popis: | Metabolic syndrome (MetS) is an important risk factor for the development of type-2 diabetes and coronary artery disease. We aimed to compare the MetS prevalence in patients with borderline personality disorder (BPD) with comparison subjects followed in primary care from a similar region. One hundred and thirty-five BPD patients according to DSM-IV diagnostic criteria were compared to 1009 subjects from primary care. We used the American Heart Association/National Heart, Lung and Blood Institute criteria to determine the rate of MetS. The age-standardized prevalence of MetS was more than double in patients with BPD compared to comparison subjects (23.3 vs. 10.6 %, p |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink